Forian Inc.
Forian Inc. (FORA) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · FORA · as of Jun 9, 2026
Key Statistics
Explore Forian Inc. Data
fora stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 3 · Buy rate: 100.0%
The FORA analyst consensus is Buy, based on ratings from 3 Wall Street analysts over the past 3 months. The average 12-month price target is $4.50, representing +107.37% upside from the current price of $2.17.
Competitors & Peers
fora competitorsFORA
AMWL
ASRT
BEAT
GEG
LUNGStock Performance
Full HistoryAbout Forian Inc.
Forian Inc. delivers advanced software solutions, proprietary data insights, and sophisticated predictive analytics. These offerings are designed to enhance the operational efficiency, clinical effect…
what is forian inc. · fora stock overview · forian inc. company profile · who is forian inc. ceo · fora NASDAQ · forian inc. headquarters · forian inc. business segments
About Stock Overview & Key Data
Forian Inc. (FORA) is a Healthcare company in the Medical - Healthcare Information Services industry, listed on NASDAQ since Mar 3, 2021. As of the latest trading session, FORA stock price is $2.17, with a market capitalization of $67.8M. The stock has returned +5.85% over the past 12 months and +2.36% year-to-date.
According to 3 Wall Street analysts, the consensus rating for Forian Inc. stock is Buy, with an average 12-month price target of $4.50. In fiscal year 2025, Forian Inc. reported revenue of $30.3M and net income of -$2.9M. For detailed data — including Forian Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Forian Inc. (FORA) stock price is $2.17. The stock is traded on NASDAQ under the ticker symbol FORA. The 52-week range is $1.64 – $2.71.